C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Revenue

In the year 2025, C4 Therapeutics had annual revenue of $35.95M with 1.02% growth. C4 Therapeutics had revenue of $6.15M in the quarter ending March 31, 2026, with 18.83% growth.

• Revenue (ttm): $35.95M
• Revenue Growth: +32.15%
• P/S Ratio: 13.07
• Revenue / Employee: $335,202
• Employees: 104
• Market Cap: 455.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.95M	363.00K	1.02%
Dec 31, 2024	35.58M	4.49M	14.43%
Dec 31, 2022	31.10M	-14.69M	-32.08%
Dec 31, 2021	45.79M	12.59M	37.93%
Dec 31, 2020	33.20M	11.81M	55.25%
Dec 31, 2019	21.38M	2.02M	10.42%
Dec 31, 2018	19.36M	-	-

Data Source: Fiscal.ai Last updated: May 12, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error